Wateya "Paqij" çi ye?
Heywan mutasyon hilnagire. Wê nexweşî pêş nekeve û wê derbas neke.
Seh Dejenerasyona Pergala Pirjimar a Canine Di Crested Chinese de (CMSD-CC)
The Canine Multiple System Degeneration (CMSD) DNA test is essential for Chinese Crested dog owners and breeders. CMSD is a hereditary neurological disorder affecting this breed, leading to progressive loss of coordination and mobility. Early genetic testing helps identify carriers and affected dogs, enabling responsible breeding decisions to reduce disease incidence. By using the CMSD DNA test, breeders can ensure healthier litters and improve the overall well-being of Chinese Crested dogs. This test is simple, accurate, and vital for maintaining the breed’s genetic health. Protect your Chinese Crested with reliable CMSD DNA testing today. Stay informed and promote a healthier future for your pets.
Kurtekirin : CMSD-CC
Mutasyona analîzkirî: SERAC1 c.128+1_128+4delGTAA
Mîras: Autosomal Recessive
Acronym
CMSD-CC
Frequency çavdêrî kirin
Zehmetiya klînîkî
Dabeşkirina klînîkî
Nexweşiyên Neurolojîk
Mutasyona analîz kirin
SERAC1 c.128+1_128+4delGTAA
Mode mîras
Autosomal Recessive
Kurteya testê:
The DNA test for Canine Multiple System Degeneration (CMSD) in Chinese Crested dogs helps identify carriers and affected individuals. CMSD is a hereditary neurological disorder that leads to progressive loss of coordination and muscle control. Early detection through genetic testing allows breeders to make informed decisions and reduce the risk of passing the disease to offspring. This test is essential for maintaining the health and quality of the Chinese Crested breed. Responsible breeding practices supported by DNA testing contribute to healthier future generations.
Ji pakêtê peyda dibe: Basic
Ev testa DNA ji pakêta me dest pê dike tê de ye Basic - û di heman demê de beşek ji pakêtan e Basic, Standard, Advanced, Complete.
Pakêtên testa DNA-ê bibînin →Pakêta ku herî baş li gorî stratejiya weya çandinî an tenduristiya heywanên we tê hilbijêrin.
Understanding Canine Multiple System Degeneration (CMSD)
Canine Multiple System Degeneration (CMSD) is a progressive neurological disorder primarily affecting Chinese Crested dogs. This condition is characterized by a degeneration of nerve cells in multiple systems within the body, leading to a variety of symptoms that can significantly impact the quality of life of affected dogs.
Symptoms of CMSD
The symptoms of CMSD can vary widely among affected individuals but typically include a combination of motor dysfunction, coordination issues, and cognitive decline. Common signs may involve difficulty walking, tremors, and a general lack of coordination. As the disorder progresses, dogs may exhibit weakness in their limbs, making it challenging for them to perform routine activities such as running or jumping.
Causes and Genetic Basis
CMSD is believed to be genetically inherited, with specific mutations in the DNA linked to the condition. These mutations disrupt normal cellular functions, leading to the degeneration of nerve cells. Researchers are actively studying the genetic factors associated with CMSD to better understand its pathogenesis and to develop potential targeted therapies.
Diagnosis of CMSD
Diagnosis of CMSD typically involves a combination of clinical evaluations and genetic testing. Veterinarians will assess the dog's neurological function and may recommend imaging or other diagnostic tools to rule out other potential causes of the symptoms. Genetic testing can confirm the presence of mutations associated with CMSD, aiding in a definitive diagnosis.
Vebijarkên Rêvebir û Dermankirinê
Currently, there is no cure for CMSD; however, management strategies aim to improve the quality of life for affected dogs. Supportive care may include physical therapy to maintain mobility, nutritional support to ensure proper health, and medications to manage symptoms such as pain or anxiety. Regular veterinary check-ups are essential to monitor the dog's condition and adjust care as needed.
Importance of Genetic Testing
Genetic testing plays a crucial role in understanding CMSD and managing the health of Chinese Crested dogs. By identifying carriers of the mutation, breeders can make informed decisions to minimize the risk of this condition in future generations. Additionally, early detection through genetic testing can lead to proactive management of affected dogs, ultimately improving their quality of life.
Nijada ku ji bo ceribandinê tê nas kirin: Dejenerasyona Pergala Pirjimar a Canine Di Crested Chinese de (CMSD-CC)
- Chinese Crested
🧬 Interpretation of genotypes CMSD-CC
Genotype
Cî
🟡 N/N
Non-hilgir - No Risk
🟡 N/CMSD-CC
Carrier - No Risk
❌ CMSD-CC/CMSD-CC
Bi bandor - Di rîskê de
FAQ: têgihiştina şîroveyê
Ma "Carrier" ciddî ye?
Naxêr. Ajal bi gelemperî saxlem e lê dikare mutasyonê bigihîne xwe dûndana.
Heke heywanek "Bê bandor" be?
Ew du kopiyên mutated digire. Nîşanên klînîkî li gorî têne hêvî kirin nexweşî. Divê ew neyê çandin.
Çima di navbera nêr/mê de cudahî hene?
Hin nexweşî bi zayendî ve girêdayî ne, ji ber vê yekê vegotina wan li gorî nexweşiyê diguhere zayenda heywanan.
Pêşbînî Pêşbînî
N/N (ne-hilgir)
N/CMSD-CC (Barkêş)
CMSD-CC/CMSD-CC (Fenî)
FAQ testa DNA
Ev testa DNA-ê çi destnîşan dike?
This DNA test detects the mutation associated with Canine Multiple System Degeneration In Chinese Crested (CMSD-CC) in order to identify clear, carrier, or at-risk animals.
Çima heywanek çêdike ceribandin?
Testkirina DNA ji cotkaran re dibe alîkar ku zewacên bi ewletir plansaz bikin û xetera veguheztina mutasyonê ji nifşan re kêm bikin.
Moda mîrasê ya vê testê çi ye?
Moda mîrasê ya ku ji bo vê ceribandinê hatî ragihandin Autosomal Recessive ye.
Di vê testê de kîjan mutasyon tê analîz kirin?
This test analyses the mutation SERAC1 c.128+1_128+4delGTAA.
Ma heywanek hilgirê bi neçarî bandor dibe?
Ne hewce ye. Şîrovekirin bi şêwaza mîras û genotipa encam ve girêdayî ye.
Çavkanî
Johnson GS, Mhlanga-Mutangadura T, Morava E, Kozicz T, Taylor JF, O’Brien DP, Schnabel RD. Canine Multiple System Degeneration is Associated with Distinct SERAC1 Mutations in Two Different Dog Breeds [abstract]. Presented at the 63rd Annual Meeting of the American Society of Human Genetics in Boston, Massachusetts; 2013 Oct 22-26.